New 2,000-square-foot laboratory and office suite is a hub for research across the entire UWM campus,

Scientists peel helpful and harmful properties of a natural substance apart, harnessing the “sugar code” that lets viruses enter cells

Parietin, also known as physcion, could slow the growth of and kill human leukemia cells obtained directly from patients

Study provides a more complete and complex picture of infectious disease ecology than before

"Only a fraction of drugs that show promise in animals end up proving safe and effective in humans," lead researcher says

The most significant equipment-related trend in bioprocessing over the past 15 years has been the replacement of reusable glass and steel equipment by single-use plastics.

New software programs should help identify potential avenues for improved drug treatments for diabetes and other diseases

Sanofi, a global health care company, recently signed an agreement with the University of Texas System to fund selected research programs focused on the early stages of drug discovery.

Most drug discovery efforts begin with a biological target—the molecule inside the body whose activity the drug is expected to enhance or diminish. Assurance that the target is pharmacologically accessible and responsible in some way for the disease in question is based on target validation studies.

The Salk Institute and Sanford Burnham Prebys Medical Discovery Institute created a compound that stops a cellular recycling process.